JoVE Logo
Faculty Resource Center

Sign In

一个负选择标记的发展阿米巴

DOI :

10.3791/2410-v

6:05 min

December 12th, 2010

December 12th, 2010

12,099 Views

1Division of Infectious Disease and International Health, University of Virginia Health System

我们的报告负选择系统的发展 E。阿米巴基于嵌合蛋白的转基因表达(FCU1)和前体药物5 - 氟胞嘧啶的选择。 FCU1蛋白是一种融合酵母胞嘧啶脱氨酶和尿嘧啶phosphoribosyltransferase。 FCU1表达导致增加 E。阿米巴对5 - 氟胞嘧啶的敏感性。

Tags

46 5 UPRT CMFDA

-- Views

Related Videos

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved